Related Experiment Video

Updated: May 23, 2026

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

[MITF: a genetic key to melanoma and renal cell carcinoma?]

Corine Bertolotto, Fabienne Lesueur, Brigitte Bressac de Paillerets

    Medecine Sciences : M/S
    |April 7, 2012
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Screening for Melanoma Modifiers using a Zebrafish Autochthonous Tumor Model
    10:23

    Screening for Melanoma Modifiers using a Zebrafish Autochthonous Tumor Model

    Published on: November 13, 2012

    Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
    06:09

    Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

    Published on: June 7, 2019

    Related Experiment Videos

    Last Updated: May 23, 2026

    A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
    07:41

    A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

    Published on: March 8, 2022

    Screening for Melanoma Modifiers using a Zebrafish Autochthonous Tumor Model
    10:23

    Screening for Melanoma Modifiers using a Zebrafish Autochthonous Tumor Model

    Published on: November 13, 2012

    Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells
    06:09

    Spatial and Temporal Control of Murine Melanoma Initiation from Mutant Melanocyte Stem Cells

    Published on: June 7, 2019

    Related Concept Videos

    Mitogens and the Cell Cycle02:38

    Mitogens and the Cell Cycle

    Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
    mTOR Signaling and Cancer Progression03:03

    mTOR Signaling and Cancer Progression

    The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
    The mTOR pathway or the...

    Articles linked to this work by shared authors, journal, and citation graph.

    Deep learning analysis of breast cancer histology predicts ATM pathogenic variant carrier status.

    NPJ digital medicine·2026

    Updated ENIGMA recommendations for reporting germline variants in cancer susceptibility genes and their translation into twenty languages.

    Journal of medical genetics·2026

    Cancer risks for ATM variant heterozygotes.

    Genetics in medicine : official journal of the American College of Medical Genetics·2026

    Genome-wide association study of 398,238 women unveils seven loci associated with high-grade serous ovarian cancer.

    NPJ genomic medicine·2025

    Large-scale meta-analysis and precision functional assays identify FANCM regions in which PTVs confer different risks for ER-negative and triple-negative breast cancer.

    Breast (Edinburgh, Scotland)·2025

    SETDB1 is critically required for uveal melanoma growth and represents a promising therapeutic target.

    Cell death & disease·2025

    [Serial cloners of Yamanashi].

    Medecine sciences : M/S·2026

    [Long COVID: between a syndromic framework and an etiological imperative].

    Medecine sciences : M/S·2026

    [The Edmonton transplantation protocol, 25 years later: toward remission of type 1 diabetes?]

    Medecine sciences : M/S·2026

    [Bioinformatics and omics analyses: chronology of a new scientific approach].

    Medecine sciences : M/S·2026

    [The 2025 Nobel Prize: regulatory T lymphocytes, the long-neglected "immunosuppressive cells". A brief history of a scientific renaissance and its emergence in France].

    Medecine sciences : M/S·2026

    [Contributions of seeding amplification assays to the diagnosis of synucleinopathies].

    Medecine sciences : M/S·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us